Clinical Trial Update: Peripheral Transcutaneous Neuromodulation of the Post-tibial Nerve for Solifenacin 10 mg. Hyperactive Bladder Syndrome [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating peripheral transcutaneous neuromodulation of the posterior tibial nerve for treatment alongside solifenacin 10 mg in hy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperactive Bladder
• Urinary Incontinence

Drugs mentioned

• Peripheral transcutaneous neuromodulation of the post-tibial nerve
• Solifenacin (solifenacin)

Snippet

Sponsor: Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia | Conditions: Urinary Incontinence | Phase 4 | Status: UNKNOWN